ARK Investment Management’s Evogene EVGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-361,184
Closed -$6.02M 362
2021
Q4
$6.02M Sell
361,184
-41,735
-10% -$947K 0.02% 160
2021
Q3
$10.7M Sell
402,919
-16,415
-4% -$479K 0.03% 157
2021
Q2
$14.4M Sell
419,334
-60,334
-13% -$2.36M 0.03% 173
2021
Q1
$24.2M Buy
479,668
+20,218
+4% +$1.25M 0.05% 160
2020
Q4
$21.6M Sell
459,450
-2,435
-0.5% -$85.8K 0.06% 136
2020
Q3
$18.3M Buy
461,885
+422,361
+1,069% +$7.54M 0.11% 94
2020
Q2
$395K Buy
39,524
+13,911
+54% +$151K ﹤0.01% 174
2020
Q1
$302K Buy
25,613
+2,892
+13% +$39.8K 0.01% 157
2019
Q4
$345K Buy
22,721
+1,796
+9% +$26.8K 0.01% 178
2019
Q3
$331K Buy
20,925
+626
+3% +$9.85K 0.01% 181
2019
Q2
$327K Sell
20,299
-8,376
-29% -$155K 0.01% 172
2019
Q1
$525K Buy
28,675
+3,463
+14% +$73.2K 0.02% 125
2018
Q4
$499K Buy
25,212
+955
+4% +$24.1K 0.02% 106
2018
Q3
$754K Buy
24,257
+7,522
+45% +$217K 0.02% 105
2018
Q2
$479K Buy
16,735
+10,519
+169% +$321K 0.02% 145
2018
Q1
$197K Buy
6,216
+3,066
+97% +$114K 0.01% 161
2017
Q4
$97K Buy
3,150
+1,096
+53% +$43K 0.01% 169
2017
Q3
$91K Buy
2,054
+731
+55% +$34.8K 0.01% 127
2017
Q2
$67K Buy
1,323
+585
+79% +$30.2K 0.01% 103
2017
Q1
$39K Buy
738
+73
+11% +$3.8K 0.01% 97
2016
Q4
$34K Buy
+665
New +$38.1K 0.01% 95

Other funds holding EVGN

ARK Investment Management's EVGN Position: Q1 2022 in Review

ARK Investment Management sold out of Evogene (EVGN) in Q1 2022, closing a stake of 361,184 shares — an estimated $6.02M sold.

ARK Investment Management first reported a position in EVGN in Q4 2016 and held it in 21 quarters. The position peaked at $24.2M in Q1 2021. 38 funds tracked by Wall St. Rank hold EVGN as of Q1 2022.

  • ARK Investment Management reported no remaining Evogene position as of Q1 2022 after selling out during the quarter.
  • ARK Investment Management sold 361,184 Evogene shares in Q1 2022, an estimated $6.02M.
  • ARK Investment Management first reported a position in Evogene in Q4 2016 and held it in 21 quarters.
  • ARK Investment Management's Evogene position peaked at $24.2M in Q1 2021.
  • 38 funds tracked by Wall St. Rank held Evogene as of Q1 2022.

Based on ARK Investment Management's 13F filing for Q1 2022, filed 19 Apr 2022.